Abaxis: Cash Resources Will Allow Us To Scale Our Medical Business

Abaxis (NASDAQ:ABAX) CEO Clint Severson discusses opportunities for growth and comments on the Federal Trade Commission’s (FTC) investigation into Idexx Laboratories’ (NASDAQ:IDXX) non-compete agreement with national distributors, in an exclusive video interview with PropThink.

Severson explains how Abaxis is scaling their business on the heel of a record quarter; Abaxis reported growth in both their top and bottom line in the most recent fiscal period. The interview features thought-provoking dialogue that explores the core fundamentals of the diagnostic products business.